Small Airway Disease And Bronchial Hyperreactivity In Patients With Post Acute Covid-19 Syndrome
- Conditions
- COVID-19
- Registration Number
- NCT06374420
- Lead Sponsor
- Mansoura University
- Brief Summary
The aim of this work is to estimate the frequency of small airway disease and/or the bronchial hyperreactivity in follow up of postacute covid survivors.
- Detailed Description
This is a observational longitudinal study investigating pulmonary sequelae of covid-19.
Study site:
Mansoura university hospital, chest department and post covid outpatient clinic.
Elmahalla chest hospital and outpatients clinic.
Time of study :
Two years from September 2021 to September 2023
Target population:
Adults with confirmed covid 19 who remaining symptomatic after 30 days from the diagnosis.
Sample size The study will include 100 selected cases during period from 2021 to 2023
Patients :
The enrolled patients are adults who survived acute covid-19 and presented for clinical follow up.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 100
- Ambulatory adult patients confirmed diagnosis of covid -19 either on typical CT chest basis or PCR and passed period of acute illness (28 days from start of symptoms) but still with clinical symptoms.
- Hospitalized or requiring intensive care unit. Known patients with chronic lung diseases Uncontrolled comorbidities
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method investigating pulmonary sequelae of covid-19. 6 month The selected post covid patients on the day of their clinic visit (6 months after being diagnosed covid 19
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Mansoura University
🇪🇬Mansoura, Dakhlia, Egypt